Coronavirus Membrane Fusion Mechanism Offers a Potential Target for Antiviral Development

Overview

Journal Antiviral Res

Publisher Elsevier

Date 2020 Apr 10

PMID 32272173

Citations 417

Authors

Tiffany Tang

Miya Bidon

Javier A Jaimes

Gary R Whittaker

Susan Daniel

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has focused attention on the need to develop effective therapies against the causative agent, SARS-CoV-2, and also against other pathogenic coronaviruses (CoV) that have emerged in the past or might appear in future. Researchers are therefore focusing on steps in the CoV replication cycle that may be vulnerable to inhibition by broad-spectrum or specific antiviral agents. The conserved nature of the fusion domain and mechanism across the CoV family make it a valuable target to elucidate and develop pan-CoV therapeutics. In this article, we review the role of the CoV spike protein in mediating fusion of the viral and host cell membranes, summarizing the results of research on SARS-CoV, MERS-CoV, and recent peer-reviewed studies of SARS-CoV-2, and suggest that the fusion mechanism be investigated as a potential antiviral target. We also provide a supplemental file containing background information on the biology, epidemiology, and clinical features of all human-infecting coronaviruses, along with a phylogenetic tree of these coronaviruses.

Citing Articles

Molecular imaging of viral pathogenesis and opportunities for the future.

Kelly B, Boudreau J, Beyea S, Brewer K Npj Imaging. 2025; 3(1):3.

PMID: 39872292 PMC: 11761071. DOI: 10.1038/s44303-024-00056-w.

SARS-CoV-2 FP1 Destabilizes Lipid Membranes and Facilitates Pore Formation.

Sumarokova M, Pavlov R, Lavushchenko T, Vasilenko E, Kozhemyakin G, Fedorov O Int J Mol Sci. 2025; 26(2).

PMID: 39859399 PMC: 11765642. DOI: 10.3390/ijms26020686.

Probing SARS-CoV-2 membrane binding peptide via single-molecule AFM-based force spectroscopy.

Zhang Q, Rosa R, Ray A, Durlet K, Dorrazehi G, Bernardi R Nat Commun. 2025; 16(1):6.

PMID: 39747000 PMC: 11696146. DOI: 10.1038/s41467-024-55358-9.

Dimethoxycurcumin Acidifies Endolysosomes and Inhibits SARS-CoV-2 Entry.

Khan N, Afghah Z, Baral A, Geiger J, Chen X Front Virol. 2024; 2.

PMID: 39677976 PMC: 11638979. DOI: 10.3389/fviro.2022.923018.

Very broad distribution of β sheet registries of the HIV gp41 fusion peptide supports mutational robustness for fusion and infection.

Zhang Y, Schmick S, Xie L, Ghosh U, Weliky D Proc Natl Acad Sci U S A. 2024; 121(50):e2402953121.

PMID: 39621921 PMC: 11648660. DOI: 10.1073/pnas.2402953121.

References

Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X . Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. Biochem Biophys Res Commun. 2004; 319(3):746-52. PMC: 7111000. DOI: 10.1016/j.bbrc.2004.05.046. View

Madu I, Belouzard S, Whittaker G . SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology. 2009; 393(2):265-71. PMC: 3594805. DOI: 10.1016/j.virol.2009.07.038. View

Jaimes J, Millet J, Stout A, Andre N, Whittaker G . A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses. Viruses. 2020; 12(1). PMC: 7019228. DOI: 10.3390/v12010083. View

Dyall J, Coleman C, Hart B, Venkataraman T, Holbrook M, Kindrachuk J . Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014; 58(8):4885-93. PMC: 4136000. DOI: 10.1128/AAC.03036-14. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Gao J, Lu G, Qi J, Li Y, Wu Y, Deng Y . Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol. 2013; 87(24):13134-40. PMC: 3838252. DOI: 10.1128/JVI.02433-13. View

Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

Reinke L, Spiegel M, Plegge T, Hartleib A, Nehlmeier I, Gierer S . Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS One. 2017; 12(6):e0179177. PMC: 5479546. DOI: 10.1371/journal.pone.0179177. View

Bosch B, Martina B, van der Zee R, Lepault J, Haijema B, Versluis C . Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A. 2004; 101(22):8455-60. PMC: 420415. DOI: 10.1073/pnas.0400576101. View

10.

van Doremalen N, Miazgowicz K, Milne-Price S, Bushmaker T, Robertson S, Scott D . Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. J Virol. 2014; 88(16):9220-32. PMC: 4136254. DOI: 10.1128/JVI.00676-14. View

11.

Dube M, Rey F, Kielian M . Rubella virus: first calcium-requiring viral fusion protein. PLoS Pathog. 2014; 10(12):e1004530. PMC: 4256232. DOI: 10.1371/journal.ppat.1004530. View

12.

Lu L, Liu Q, Zhu Y, Chan K, Qin L, Li Y . Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014; 5:3067. PMC: 7091805. DOI: 10.1038/ncomms4067. View

13.

Matsuyama S, Shirato K, Kawase M, Terada Y, Kawachi K, Fukushi S . Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells. J Virol. 2018; 92(19). PMC: 6146822. DOI: 10.1128/JVI.00683-18. View

14.

Widagdo W, Okba N, Li W, de Jong A, de Swart R, Begeman L . Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors. J Virol. 2019; 93(16). PMC: 6675889. DOI: 10.1128/JVI.00107-19. View

15.

Chambers P, Pringle C, Easton A . Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol. 1990; 71 ( Pt 12):3075-80. DOI: 10.1099/0022-1317-71-12-3075. View

16.

Mingo R, Simmons J, Shoemaker C, Nelson E, Schornberg K, DSouza R . Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol. 2015; 89(5):2931-43. PMC: 4325712. DOI: 10.1128/JVI.03398-14. View

17.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

18.

Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y . Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res. 2016; 27(1):119-129. PMC: 5223232. DOI: 10.1038/cr.2016.152. View

19.

Dube M, Etienne L, Fels M, Kielian M . Calcium-Dependent Rubella Virus Fusion Occurs in Early Endosomes. J Virol. 2016; 90(14):6303-6313. PMC: 4936153. DOI: 10.1128/JVI.00634-16. View

20.

Tripet B, Howard M, Jobling M, Holmes R, Holmes K, Hodges R . Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem. 2004; 279(20):20836-49. PMC: 8060857. DOI: 10.1074/jbc.M400759200. View